Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 11:17 (1840 d 02:27 ago) – Posting: # 20128
Views: 3,152

❝ ❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


❝ What does your protocol say on exactly that matter?


My protocol says within (-0.20 and 0.20)

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,663 registered users;
76 visitors (0 registered, 76 guests [including 5 identified bots]).
Forum time: 13:45 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5